Evidence map›Paper›PMID 29482055›Full record

ArticleDrug and alcohol dependence2018

Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico.

Danielle Horyniak, Steffanie A Strathdee, Brooke S West, Meredith Meacham, Gudelia Rangel, Tommi L Gaines

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. HIV and Substance Use in Latin America: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Danielle HoryniakDivision of Global Public Health, University of California San Diego, La Jolla, CA, 92093, United States; Behaviours and Health Risks Program, Burnet Institute, Melbourne, VIC, 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.
Steffanie A StrathdeeDivision of Global Public Health, University of California San Diego, La Jolla, CA, 92093, United States.
Brooke S WestDivision of Global Public Health, University of California San Diego, La Jolla, CA, 92093, United States.
Meredith MeachamDepartment of Psychiatry, University of California San Francisco, San Francisco, CA, 94143, United States.
Gudelia RangelUnited States-Mexico Border Health Commission, Tijuana, BC, 22320, Mexico.
Tommi L GainesDivision of Global Public Health, University of California San Diego, La Jolla, CA, 92093, United States. Electronic address: togaines@ucsd.edu.
University of California San Diego · USBurnet Institute · AUUniversity of California, San Francisco · US

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in TijuanaR37DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2019
$6.7M
Venues and Risk Networks: Context of Substance Use and HIV among High Risk WomenK01DA041233 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEST, BROOKE S. · 2016 to 2020
$921k
Modeling the Complex Dynamics between Behaviors and Environments Shaping HIV/STIsK01DA034523 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GAINES, TOMMI LYNN · 2012 to 2016
$905k
NIDA NIH HHS K01 DA034523NIDA NIH HHS K01 DA041233NIDA NIH HHS R37 DA019829NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

introductionLittle is known about the cessation of injecting drug use (IDU) among people who inject drugs (PWID) in low and middle-income settings, where access to effective interventions for reducing drug use (e.g., opioid substitution treatment; OST), may be limited. We measured the incidence and identified predictors of IDU cessation among a cohort of PWID in Tijuana, Mexico.

methodsData were drawn from 621 participants in Proyecto El Cuete IV, a prospective cohort of PWID recruited in 2011 and interviewed biannually to 2016. A multivariable Extended Cox model was constructed to identify socio-demographic, drug use, risk environment and health-related predictors of IDU cessation (no IDU for ≥six months).

results141 participants (23%) reported at least one IDU cessation event during follow-up. The crude IDU cessation rate was 7.3 per 100 person-years (95% Confidence Interval [CI]: 6.2-8.7). IDU cessation was negatively associated with injecting at least daily on average and heroin/methamphetamine co-injection in the past six months, and positively associated with testing HIV positive at baseline, being on methadone maintenance therapy in the past six months, and recent arrest. Concern for personal safety was also independently associated with IDU cessation.

conclusionsThe rate of IDU cessation among PWID in Tijuana was low. These findings underscore the importance of expansion of services including OST to help reduce drug use and facilitate IDU cessation for those who wish to do so. In this setting, interventions addressing individual-level economic barriers as well as broader social and structural barriers to harm reduction services are integral.

Indexed as

Drug UsersHealth BehaviorAdultFemaleHeroinHumansIncidenceMaleMethamphetamineMexicoProspective StudiesRisk FactorsSubstance Abuse, IntravenousHeroinMethamphetamineCessationInjecting drug useMexico

Identifiers

PMID29482055
PMCPMC5889739
OpenAlexW2789831418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.